Today: 10 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Warner Bros. Discovery (WBD) Stock: Netflix Deal, Paramount Bid, and Key Numbers to Watch Before the Market Opens on Dec. 22, 2025

Warner Bros. Discovery (WBD) Stock: Netflix Deal, Paramount Bid, and Key Numbers to Watch Before the Market Opens on Dec. 22, 2025

WBD shares closed near $27.77 ahead of Monday’s open, tracking the value of competing takeover bids from Netflix and Paramount Skydance. Netflix has offered $27.75 per share in cash and stock, while Paramount is pitching a $30 all-cash deal. The stock price reflects investor bets on which bid will prevail. Regulatory review and deal terms remain in focus.
22 December 2025
···
Palo Alto Networks (PANW) Stock: What to Know Before the U.S. Market Opens on Dec. 22, 2025

Palo Alto Networks (PANW) Stock: What to Know Before the U.S. Market Opens on Dec. 22, 2025

Palo Alto Networks and Google Cloud have expanded their partnership in a security services deal reportedly worth nearly $10 billion over several years, Reuters reported Dec. 19. PANW shares last closed at $186.88. The agreement includes AI-driven cybersecurity initiatives and deeper integration of Palo Alto’s platforms with Google Cloud services. Investors are watching for further details on margins and execution.
22 December 2025
·
Merck (MRK) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Merck (MRK) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Merck announced a new U.S. drug-pricing agreement, pledging to offer Januvia and related diabetes drugs at about 70% off list prices through a direct-to-patient program. The company also reached a deal with the Commerce Department to delay Section 232 tariffs for three years. Merck shares closed at $101.09, near the top of their 52-week range. The next earnings report is expected in early February 2026.
22 December 2025
·
Home Depot Stock (HD): What Investors Should Know Before the Market Opens on Dec. 22, 2025

Home Depot Stock (HD): What Investors Should Know Before the Market Opens on Dec. 22, 2025

Home Depot shares closed at $345.00 Friday, down 2.8%, after the company reaffirmed fiscal 2025 guidance and issued a cautious 2026 outlook with projected total sales growth of 2.5% to 4.5%. Management emphasized a shift toward Pro customers and productivity. Housing market data showed modest improvement but ongoing constraints. A reported security issue involving leaked credentials also surfaced.
22 December 2025
·
Qualcomm (QCOM) Stock: What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Earnings Forecasts, and Analyst Outlook

Qualcomm (QCOM) Stock: What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Earnings Forecasts, and Analyst Outlook

Qualcomm closed at $175.25 on Dec. 19, 2025, with after-hours trading at $175.75 and a market cap near $186 billion. The company completed its Alphawave Semi acquisition on Dec. 18, accelerating its data center AI push. Tony Pialis, Alphawave’s CEO, will lead Qualcomm’s data center business. Next earnings are scheduled for Feb. 4, 2026.
22 December 2025
···
Bank of America (BAC) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Bank of America (BAC) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Bank of America shares closed Friday at $55.27, up 1.86% on heavy volume ahead of the holiday week. Oppenheimer raised its price target to $63 from $55, maintaining an “outperform” rating. The next earnings report is set for Jan. 14, with analysts expecting Q4 EPS of about $0.96, up from $0.82 a year ago. CEO Brian Moynihan recently signaled potential high single-digit to 10% growth in trading revenue for Q4.
22 December 2025
·
Mastercard (MA) Stock: What to Know Before the Market Opens on December 22, 2025

Mastercard (MA) Stock: What to Know Before the Market Opens on December 22, 2025

Mastercard shares closed at $572.23 on Friday ahead of the U.S. market reopening Monday, with analysts maintaining a “Strong Buy” consensus and average price targets in the mid-$600s. The company faces ongoing litigation over a proposed $38 billion swipe-fee settlement, which major retailers have urged a judge to reject, citing insufficient relief.
22 December 2025
Goldman Sachs Stock (GS): What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Analyst Forecasts, and Key Catalysts

Goldman Sachs Stock (GS): What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Analyst Forecasts, and Key Catalysts

Goldman Sachs closed at $893.48 on Dec. 19, near its 52-week high of $919. Wall Street rates the stock “Hold” with a mean 1-year price target of $793. The firm’s Q4 2025 earnings are scheduled for Jan. 15, 2026. Goldman has reorganized its investment-banking teams around AI and digital infrastructure and agreed to acquire Innovator Capital Management.
22 December 2025
·
Citigroup (C) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Citigroup (C) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Citigroup shares closed at $114.86 on Friday, near 2025 highs, as investors weighed recent regulatory relief. The Federal Reserve ended three confidential supervisory actions tied to trading risk, and the OCC removed a 2024 amendment to Citi’s 2020 consent order. Citi’s Q4 earnings are set for Jan. 14, 2026. The underlying 2020 consent order remains in effect.
22 December 2025
·
AbbVie Stock (ABBV) Before the Market Opens on Dec. 22, 2025: Drug-Pricing Talks, Dividend Signals, and the Next Catalysts

AbbVie Stock (ABBV) Before the Market Opens on Dec. 22, 2025: Drug-Pricing Talks, Dividend Signals, and the Next Catalysts

AbbVie closed at $226.82 on Friday, Dec. 19, up 1.8%, with trading volume spiking to 18.6 million shares, well above average. The company remains in talks with the White House as U.S. drug pricing reforms accelerate, including “most-favored-nation” deals and new TrumpRx programs. AbbVie is expected to visit the White House after the holidays for further negotiations.
22 December 2025
···
Alnylam Pharmaceuticals (ALNY) Stock: Nasdaq-100 Entry, Amvuttra Momentum, Analyst Targets and Key Risks to Know Before the Dec. 22, 2025 Market Open

Alnylam Pharmaceuticals (ALNY) Stock: Nasdaq-100 Entry, Amvuttra Momentum, Analyst Targets and Key Risks to Know Before the Dec. 22, 2025 Market Open

Alnylam Pharmaceuticals joins the Nasdaq-100 before the U.S. market opens Dec. 22, prompting index-tracking funds to adjust positions. Shares last closed at $400.23. The company’s drug Amvuttra recently secured routine NHS use in England and Health Canada approval for ATTR cardiomyopathy. Alnylam also announced a $250 million manufacturing expansion and new FDA recognition for its technology platform.
22 December 2025
···
Johnson & Johnson Stock (JNJ) Before the Market Opens on December 22, 2025: FDA Catalysts, Talc Litigation Headlines, Analyst Targets, and What to Watch

Johnson & Johnson Stock (JNJ) Before the Market Opens on December 22, 2025: FDA Catalysts, Talc Litigation Headlines, Analyst Targets, and What to Watch

Johnson & Johnson shares closed at $206.37 on Friday, about 4% below their 52-week high. A Minnesota jury awarded $65.5 million in a talc cancer case against the company, which plans to appeal. The FDA granted a priority review voucher for J&J’s Tecvayli-Darzalex multiple myeloma regimen, speeding regulatory timelines. Trading may see sharper moves this week due to holiday liquidity.
22 December 2025
Exxon Mobil (XOM) Stock: Key News, Analyst Forecasts, and What to Watch Before the U.S. Market Opens on Dec. 22, 2025

Exxon Mobil (XOM) Stock: Key News, Analyst Forecasts, and What to Watch Before the U.S. Market Opens on Dec. 22, 2025

Exxon Mobil shares last traded at $116.69, down 1.02%, as crude prices hover near multi-year lows. Oil rebounded early Dec. 22 after the U.S. intercepted a Venezuelan tanker, but remains volatile. Exxon updated its 2030 plan, targeting $25 billion earnings growth and raising output goals. CFO Kathy Mikells will retire Feb. 1, 2026, with Neil Hansen set to succeed her.
22 December 2025
·
Salesforce Stock (NYSE: CRM): Key News, Analyst Forecasts, and What to Watch Before the U.S. Market Opens on Dec. 22, 2025

Salesforce Stock (NYSE: CRM): Key News, Analyst Forecasts, and What to Watch Before the U.S. Market Opens on Dec. 22, 2025

Salesforce shares closed at $259.91 on Dec. 19, down nearly 21% year-to-date but up 14.6% for the month. The company announced a deal to acquire Qualified, an AI marketing firm, on Dec. 17. In its latest earnings, Salesforce reported Q3 revenue of $10.3 billion, up 9% year-over-year, and highlighted Agentforce and Data 360 annualized revenue reaching $1.4 billion, up 114%.
22 December 2025
·
Microsoft AI CEO Mustafa Suleyman Draws Superintelligence Red Lines as Costs, Talent Wars and Power Bills Collide

Microsoft AI CEO Mustafa Suleyman Draws Superintelligence Red Lines as Costs, Talent Wars and Power Bills Collide

Microsoft AI CEO Mustafa Suleyman said on Dec. 21 the company will halt any AI system that risks escaping human control, calling “containment” and “alignment” non-negotiable before releasing superintelligent tools. On the same day, U.S. senators pressed Microsoft and other firms on whether AI data centers are raising household electricity bills as their power use climbs.
22 December 2025
··
Starbucks Names Former Amazon Grocery Tech Leader Anand Varadarajan as CTO in Brian Niccol’s Turnaround Push

Starbucks Names Former Amazon Grocery Tech Leader Anand Varadarajan as CTO in Brian Niccol’s Turnaround Push

Starbucks named Anand Varadarajan, a longtime Amazon executive, as its new Chief Technology Officer, effective January 19, 2026. Varadarajan will oversee technology upgrades aimed at improving store speed and labor efficiency, following the previous CTO’s departure in the fall. CEO Brian Niccol is pushing a tech overhaul to address operational challenges in U.S. stores.
22 December 2025
·
1 … 516 517 518 519 520 … 694
Go toTop